期刊文献+

恶性脑胶质瘤术后低分割放疗对患者预后的影响 被引量:3

Effect of Low-segment Radiotherapy on Prognosis of Patients with Malignant Glioma
下载PDF
导出
摘要 目的探讨恶性脑胶质瘤术后低分割放疗对患者预后的影响。方法选择60例恶性脑胶质瘤患者作为研究对象,随机将其分为治疗组24例与对照组36例,治疗组术后采取低分割放疗,对照组术后采取常规分割放疗。采用Kaplan-Merier法计算无进展生存率与总生存率,记录不良反应及生活质量。结果治疗组的中位无进展生存期为3.6个月(1.6~8.7个月),对照组的中位无进展生存期为2.3个月(1.0~6.9个月),组间比较差异存在统计学意义(P<0.05)。治疗组存活7例,死亡15例,失访2例,中位生存期为17.4个月(4.2~41.5个月);对照组存活11例,死亡22例,失访3例,中位生存期为16.9个月(3.7~42.8个月),组间比较差异尚未达到统计学意义(P>0.05)。2组均有患者出现急性放射性脑水肿,治疗组3例,对照组4例,组间比较差异尚未达到统计学意义(P>0.05)。2组患者治疗前生活质量评价无差异(P>0.05),治疗后2组的生活质量评价均升高,且治疗组显著高于对照组(P<0.05)。结论恶性脑胶质瘤术后采取低分割放疗可改善患者的生活质量,明显延长患者的无进展生存期,但在总生存期上并未体现出明显优势。 Objective To investigate the effect of low-segment radiotherapy on the prognosis of patients with malignant glioma.Methods 60 patients with malignant glioma were randomly divided into the treatment group(24 cases)and the control group(36 cases).The progression free survival and overall survival rate were calculated by Kaplan-Merier method,and adverse reactions and life quality evaluation were recorded.Results The median progression-free survival was 3.6 months(1.6~8.7 months)in the treatment group and 2.3 months(1.0~6.9 months)in the control group.The difference was statistically significant(P<0.05).The median survival time of the treatment group was 17.4 months(4.2~41.5 months)and that of the control group was 16.9 months(3.7~42.8 months).There were 3 cases in the treatment group and 4 cases in the control group.There was no significant difference between the 2 groups(P>0.05).There was no difference in life quality evaluation between the 2 groups(P>0.05).After treatment,the life quality evaluation of the 2 groups was increased,and the treatment group was significantly higher than the control group(P<0.05).Conclusion Low-fraction radiotherapy after malignant glioma surgery can improve the quality of life of patients and significantly prolong the progression-free survival period of patients,but it does not show an obvious advantage in the overall survival period.
作者 赵诚 李照建 张本超 王明阳 宋海洋 张桂波 ZHAO Cheng;LI Zhaojian;ZHANG Benchao(The People's Hospital of West Coast New Area in Qingdao,Qingdao,266400)
出处 《实用癌症杂志》 2019年第11期1861-1864,共4页 The Practical Journal of Cancer
关键词 恶性脑胶质瘤 低分割放疗 预后 生活质量 Malignant glioma Low-segment radiotherapy Prognosis Life quality evaluation
  • 相关文献

参考文献11

二级参考文献82

  • 1陆小军,吴新光,雷风,刘玉猛,叶亦菁,郑斯明.替膜唑胺联合放疗与单纯放疗治疗60例术后Ⅱ-Ⅳ级恶性胶质瘤的疗效比较[J].中国神经肿瘤杂志,2005,3(3):216-219. 被引量:3
  • 2董伦,浦佩玉,王虎,王广秀,康春生,焦德让.EGFR、p53与Ki-67在国人胶质瘤中表达研究[J].中华神经外科杂志,2006,22(7):442-444. 被引量:9
  • 3杨芝萍,李金瑞.三维适形放疗技术在恶性肿瘤治疗中的应用[J].实用肿瘤学杂志,2006,20(6):519-520. 被引量:16
  • 4师蔚,郭振宇.脑胶质瘤发病机制、诊断与治疗的研究进展[J].中华神经医学杂志,2007,6(9):869-871. 被引量:22
  • 5Wen PY, Kesari S. Malignant Gliomas in Adults[J]. N Engl J Med,20,08, 359(5): 492-507.
  • 6Scoccianti S, Magrini SM, Ricardi U, et al. Patterns of careand survival in a retrospective analysis of 1059 patients withglioblastoma multiforme treated between 2002 and 2007:a multicenter study by the Central Nervous System StudyGroup of Airo (Italian Association of Radiation Oncology)[J].Neurosurgery, 2010, 67(2): 446-58.
  • 7Narayana A, Yamada J, Berry S, et al. Intensity-modulatedradiotherapy in high-grade glioma: clinical and dosimetricresults[J]. Int J Radiat Oncol Biol Phys, 2006, 64(3): 892-7.
  • 8Tanaka M, Ino Y, Nakagawa K, et al. High-dose conformalradiotherapy for supratentorial malignant glioma: a historicalcomparison[J]. Lancet Oncol, 2005, 6(12): 953-60.
  • 9Cardinale R, Won M, Choucair A, et al. A phaseⅡtrial ofaccelerated radiotherapy using weekly stereotactic conformalboost for supratentorial glioblastoma multiforme RTOG0023[J].Int J Radiat Oncol Biol Phys, 2006, 65(5): 1422-8.
  • 10Tsien C, Moughan J, Michalski JM, et al. PhaseⅠthreedimensionalconformal radiation dose escalation study in newlydiagnosed glioblastoma: Radiation Therapy Oncology Group Trial98,-03[J]. Int J Radiat Oncol Biol Phys, 2009, 73(3): 699-708.

共引文献53

同被引文献27

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部